{"organizations": [], "uuid": "78d108e93d1f57af4172bf115468c26241f25065", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/9", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/02/27/business-wire-angiodynamics-to-report-fiscal-2018-third-quarter-financial-results-on-march-29-2018.html", "country": "US", "domain_rank": 767, "title": "AngioDynamics to Report Fiscal 2018 Third Quarter Financial Results on March 29, 2018", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.003, "site_type": "news", "published": "2018-02-28T00:01:00.000+02:00", "replies_count": 0, "uuid": "78d108e93d1f57af4172bf115468c26241f25065"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/02/27/business-wire-angiodynamics-to-report-fiscal-2018-third-quarter-financial-results-on-march-29-2018.html", "ord_in_thread": 0, "title": "AngioDynamics to Report Fiscal 2018 Third Quarter Financial Results on March 29, 2018", "locations": [], "entities": {"persons": [], "locations": [{"name": "n.y.", "sentiment": "none"}, {"name": "latham", "sentiment": "none"}], "organizations": [{"name": "angiodynamics", "sentiment": "negative"}, {"name": "company", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that it will report financial results for the third quarter of fiscal year 2018 before the market open on Thursday, March 29, 2018. The Company’s management at 8:00 a.m. ET the same day to discuss the results.\nTo participate in the conference call, dial 1-877-407-0784 (domestic) or 1-201-689-8560 (international) and refer to the passcode 13677111.\nThis conference call will also be webcast and can be accessed from the “Investors” section of the AngioDynamics website at www.angiodynamics.com . The webcast replay of the call will be available at the same site approximately one hour after the end of the call.\nA recording of the call will also be available from 11:00 a.m. ET on Thursday, March 29, 2018, until 11:59 p.m. ET on Thursday, April 5, 2018. To hear this recording, dial 1-844-512-2921 (domestic) or 1-412-317-6671 (international) and enter the passcode 13677111.\nAbout AngioDynamics, Inc.\nAngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories drainage products, thrombolytic products and venous products. For more information, visit www.angiodynamics.com .\nView source version on businesswire.com : http://www.businesswire.com/news/home/20180227006246/en/\nInvestor:\nAngioDynamics, Inc.\nMichael Greiner, Executive Vice President & CFO\n518-795-1821\nSource: AngioDynamics, Inc.", "external_links": ["http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.angiodynamics.com&esheet=51765384&newsitemid=20180227006246&lan=en-US&anchor=www.angiodynamics.com&index=1&md5=15f6071420bf2721ad52da01d78b2809", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.angiodynamics.com&esheet=51765384&newsitemid=20180227006246&lan=en-US&anchor=www.angiodynamics.com&index=2&md5=6a93cd5563b3831b05507e001b6fc4b1", "http://www.businesswire.com/news/home/20180227006246/en/"], "published": "2018-02-28T00:01:00.000+02:00", "crawled": "2018-02-28T02:15:03.008+02:00", "highlightTitle": ""}